View of Advances in Gene Therapy and CRISPR-Based Interventions for Beta-Thalassemia and Sickle Cell Disease: Evaluating the Clinical Efficacy and Safety of Emerging Therapeutic Approaches in Hemoglobinopathies

Return to Article Details Advances in Gene Therapy and CRISPR-Based Interventions for Beta-Thalassemia and Sickle Cell Disease: Evaluating the Clinical Efficacy and Safety of Emerging Therapeutic Approaches in Hemoglobinopathies Download Download PDF